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NMDA receptorApolipoprotein E (apoE) is predominantly synthesized by astrocytes in the brain. In this study, we
investigated the role of apoE in astrocyte apoptosis. We demonstrated that apoE protects astrocytes
from hypoxia-induced apoptosis in a dose-dependent manner. Glutamate release from astrocytic
cultures is signiﬁcantly lower from WT mice than from apoE knockout mice. Furthermore, the pro-
tective effect of apoE is mimicked by an NMDA receptor antagonist, MK-801. Finally, the apoE acti-
vator T0901317 signiﬁcantly reduced the effect of glutamate-induced apoptosis of astrocytes. These
results suggest that apoE protects astrocytes from hypoxia-induced apoptosis associated to NMDA
receptor activation. Approaches that elevate apoE secretion in astrocytes might provide a novel
strategy in the protection of neuronal ischemic injury.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hypoxia is the most common cause of cell damage in the brain.
It can occur during ischemic strokes, trauma, or atherosclerosis.
Astrocytes, the predominant cell type in the brain, are thought to
be relatively more resistant to hypoxic damage than neurons.
However, astrocytes are the ﬁrst cells that suffer ischemic insult
among all types of neural cells, because their end feet directly sur-
round capillaries [1]. Hypoxia-activated astrocytes can kill neigh-
boring neurons through the release of cytotoxic mediators [2].
Additionally, mounting evidence has indicated that alterations in
astrocyte play a crucial role in the pathogenesis of other disorders,
such as brain edema [3], inﬂammatory demyelinating diseases [4],
neurodegenerative disorders [5] and infectious diseases [6]. While
most research is focused on the direct protection of neuronal cells,
the role of non-neuronal cells, such as astrocytes that may be func-
tional in the pathogenesis of these disorders, is relatively unclear.
Apolipoprotein E (apoE), the major apolipoprotein in the CNS, is
predominantly synthesized by astrocytes. Several lines of evidence
point to a direct role of apoE in modulating neuronal response to
injury. ApoE expression is up-regulated in rat brains after ischemia
[7]. Our recent studies demonstrate that mechanical injury of neu-rons leads to increased astrocyte apoE expression and uptake [8],
which may result in lipids redistribution and neuronal and synap-
tic repairs [9]. ApoE-deﬁcient mice show increased ischemic neu-
ronal damage [10]. Intraventricular infusion of apoE ameliorates
acute neuronal death after global cerebral ischemia [11]. In this
study, we showed that apoE protected astrocytes from hypoxia-in-
duced apoptosis in a dose–response manner, the mechanism of the
protection was related to a reduction of glutamate toxicity after
exposing astrocytes to hypoxia. Taken together, our results suggest
that targeting astrocyte protection and enhancing astrocyte apoE
secretion may present a new strategy to reduce ischemic brain
injury.
2. Materials and methods
All animal procedures were approved by the Animal Care and
Use Committee at Chongqing Medical University.
2.1. Preparation of cerebral cortical astrocyte cultures
Primary cultures of cerebral cortical astrocytes were prepared
from WT/apoE KO mice (C57BL/6J; postnatal 1 d; provided by
the Experimental Animal Center of Chongqing Medical Univer-
sity.) as described previously [8]. Brieﬂy, meninges-free cortices
were cut into small cubes (<1 mm3) and incubated with 0.25%
trypsin (Sigma) for 20 min at 37 C before addition of fetal serum
to terminate digestion. The dissociated cells were incubated in
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95% O2. After 8–10 days in culture, the culture dishes were shaken
for 14 h to remove microglia and oligodendrocytes. The attached
astrocytes were removed from dishes by trypsinization and
seeded onto six-well plates on day in vitro (DIV) 14. The purity
of astrocytes was assessed by staining with glial ﬁbrillary acidic
protein (GFAP).
2.2. Astrocytes with hypoxia
Astrocytes were exposed to hypoxia to simulate hypoxic
conditions in vitro as previously described [12]. After astrocytes
became conﬂuent in culture dishes, the medium was replaced
with glucose- and serum-free DMEM, and then placed in an incu-
bator (Thermo forma, USA) perfused with a gas mixture consisting
of 1% oxygen, 5% carbon dioxide, and 94% nitrogen at 37 C for
6 h.
2.3. Transmission electron microscopy studies
Cell morphology was determined by using transmission elec-
tron microscopy [13]. Brieﬂy, astrocytes were ﬁxed with 4% glutar-
aldehyde (Amresco, USA) and 1% osmic acid (Wako, Japan, pH 7.3).
The ﬁxed astrocytes were dehydrated with a series of increasing
concentrations of cold ethanol before embedding in epoxy and
being sliced into ultrathin sections. Ultrathin sections were stained
with uranyl acetate (Amresco, USA) and lead citrate (MP, USA), and
then examined under a transmission electron microscope (H-7500,
Hitachi Japan).
2.4. Assessment of apoptosis by ﬂow cytometric assay
We used Annexin V/FITC kit (Beyotime, China) to bind annex-
in-V, which has a strong afﬁnity for phosphatidylserine and can
probe for apoptosis [14]. After exposure to hypoxia, astrocytes
were harvested and rinsed twice in cold phosphate buffer saline
(PBS, pH 7.4) at a ﬁnal cell density of 106 cells/ml. Approximately
105 cells were incubated in the dark with annexin V (Annexin
V-FITC) and propidium iodide (Beyotime, China) according to
manufacturer’s protocol. Cell samples were analyzed by ﬂow
cytometry (BD, USA).
2.5. Measurement of extracellular glutamate
The culture of astrocytes exposed to hypoxia was collected into
the centrifuge tube and centrifuged at 800 rpm for 5 min to remove
cellular debris. The concentration of glutamate in the culture was
determined using the Hitachi L-8800 automatic amino acid ana-
lyzer (Hitachi, Japan) as described by Yin et al. [15].
2.6. Exposure to glutamate
Glutamate (Sigma, USA) dissolved in DMEM/F12 was added to
the culture at a ﬁnal concentration of 50 mM [16]. The astrocytes
were then returned to the incubator and maintained at 37 C for
an additional 24 h for determination of apoptosis rate as described
above.
2.7. Statistical analysis
All experiments were done in at least triplicates. Results were
expressed as mean ± SD. Statistical analysis was carried out by
SPSS software. The signiﬁcance of statistical differences among
groups was determined by one or two-way analysis of variance
(ANOVA). Values at P < 0.05 were considered to be statistically
signiﬁcant.3. Results
3.1. Electron microscopy studies indicated that ischemic astrocytes
underwent apoptotic cell death
All organelles appeared intact before ischemia incubation and
chromatin was evenly distributed in the nucleus of a typical astro-
cyte (Fig. 1A). At 6 h of ischemia, swollen mitochondria were
shown in the cytoplasm (Fig. 1B) and cells were shrunken and pyk-
notic. The astrocyte nuclear chromatin appeared to be at various
phases of condensation and fragmentation, which are distinctive
features of apoptosis. Apoptotic bodies were also observed
(Fig. 1C).3.2. Protective effect of apoE on hypoxia induced astrocyte apoptosis
To determine whether apoE was involved in the pathological
process of hypoxia-induced astrocyte apoptosis, we measured the
apoptosis rate of astrocytes extracted from WT/apoE KO mice by
ﬂow cytometry analysis. When treated with hypoxia alone, the
apoptosis rate in the WT mice was signiﬁcantly lower than that
in apoE KO mice (Fig. 2).
Next, we added T0901317 to the culture (Cayman, USA), a liver
X receptor agonist, which up-regulates of apoE mRNA and protein
in astrocytes [17,18]. We found that the presence of T0901317
(300 nM added 48 h prior to hypoxia and maintained in the culture
media throughout the experiment) signiﬁcantly reduced hypoxia-
induced apoptosis in WT astrocytes, but it had no effect on apoE
KO astrocytes (Fig. 2).
To further demonstrate the protective role of apoE on hypoxic
injury in astrocytes, we performed additional studies to investigate
whether a dose–response relationship exists in this protection.
ApoE KO astrocytes were pretreated with apoE3 (Peprotech, 0–
3000 nM) 30 min before exposure to hypoxia and maintained in
the culture media throughout the experiment. The apoptosis rate
of astrocytes was determined 6 h later. As shown in Fig. 3, pretreat-
ment with 300nM to 3 lM of apoE3 resulted in partial protection.
Higher concentrations of apoE3 were not tested, as they were not
biologically relevant.3.3. Role of glutamate in apoE protection against hypoxia-induced
astrocyte apoptosis
Many studies have demonstrated that astrocytes undergo pro-
gramed cell death when exposed to glutamate [2,16,19]. The exces-
sive release of glutamate from astrocytes is an important mediator
of postischemic brain damage [20]. To investigate whether apoE
protects astrocytes from hypoxia-induced apoptosis by reducing
glutamate excitotoxicity, we used the Hitachi L-8800 automatic
amino acid analyzer to determine the level of extracellular gluta-
mate around the astrocytes. The glutamate concentration in the
culture of astrocytes was increased signiﬁcantly after being ex-
posed to hypoxia for 6 h, especially in the apoE KO astrocytes. Un-
der hypoxic condition, pretreatment with T0901317 (300 nM
added 48 h prior to hypoxia and maintained in the culture media
throughout the experiment) dramatically reduced the ischemia-in-
duced increase of extracellular glutamate around WT astrocytes.
However, this effect was not observed in apoE KO astrocytes
(Fig. 4).
It has previously been shown that exposing neuronal cultures to
hypoxia stimulates the release of glutamate, which causes cell
death by activating NMDA receptors [2]. To test whether the pro-
tective effects of apoE on hypoxic injury are mediated by NMDA
receptor mediated excitotoxic damage, we pretreated apoE KO
astrocytes with the NMDA receptor antagonist, MK-801(Sigma,
Fig. 1. Ultrastructure of astrocytes exposed to hypoxia for 6 h. (A) Control cells; (B) swollen mitochondria were observed in the cytoplasm (arrowhead); (C) apoptotic bodies
were found in 6 h ischemic astrocytes. Scale bar = 1 lm.
Fig. 2. Protective effect of apoE on hypoxia-induced apoptosis in astrocytes. No
effect of T0901317 (300 nM added 48 h prior to hypoxia and maintained in the
culture media throughout the experiment) was observed for hypoxia-treated apoE
KO astrocytes; apoptosis rate of the cells was determined by FCM. ⁄P < 0.05 for
hypoxia treated apoE WT astrocytes compared to apoE KO astrocytes; #P < 0.05 for
hypoxia + T0901317 treated apoE WT astrocytes compared with hypoxia-treated
apoE WT astrocytes.
Fig. 3. Dose–response relations of apoE and hypoxia-induced apoptosis in astro-
cytes. Primary apoE KO astrocytes were pretreated with apoE3 (0–3000 nM) 30 min
before exposure to hypoxia. Apoptosis rate of astrocytes was determined 6 h later.
Signiﬁcant protection was observed at 300–3000 nM compared with hypoxia alone.
⁄P < 0.05 compared with hypoxia alone.
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astrocytes from hypoxia-induced astrocyte apoptosis. The protec-
tive effect of MK801 was similar to that observed in sister cultures
exposed to hypoxia after pretreatment with 1 mM apoE3. More-
over, the effects of MK-801 and apoE were not additive, that is,
no further protection was observed in cultures pretreated with
both MK-801 and apoE prior to hypoxia exposure (Fig. 5).
3.4. The direct effects of apoE on glutamate toxicity in astrocyte
cultures
Like neurons, astrocytes are vulnerable to glutamate insults. In
order to evaluate if apoE could prevent glutamate toxicity in astro-
cyte cultures, we measured the apoptosis rate of astrocytes from
WT/apoE KO mice, using the ﬂow cytometry analysis. As shown
in Fig. 6, a signiﬁcant excitotoxic response was observed in cultures
exposed to 50 mM glutamate for 24 h both in WT astrocytes and
apoE KO astrocytes, but the apoptosis rate in WT astrocytes was
signiﬁcantly decreased compared with apoE KO astrocytes. We
also found that pretreatment with T0901317 (300 nM added 48 h
prior to glutamate exposure and maintained in the culture media
throughout the experiment) conferred partial protection against
glutamate-induced apoptosis in WT astrocytes. However, no
T0901317 protection was observed in apoE KO astrocyte cultures.
4. Discussion
The major ﬁnding of this study is that apoE protected astrocytes
from hypoxia-induced apoptosis in a dose dependent manner.
ApoE appears to exert its protective effect both by reducing the le-
vel of extracellular glutamate around the astrocytes and decreasing
the activation of NMDA receptors triggered by hypoxia.
ApoE-deﬁcientmice have served as amodel for neuronal damage
and hypoxia susceptibility, as evidenced by a series of studies asso-
ciating the apoE-deﬁcient brain with a higher sensitivity to hypoxic
damage [10,21,22]. In our study, we showed that hypoxia can in-
duce apoptosis in astrocytes, consistent with previous observations
[23]. Then we demonstrated that the presence of apoE protected
astrocytes from hypoxia induced apoptosis in WT mice. These ef-
fects were partially enhanced by T0901317, the agonist of liver X
receptor, which upregulates apoE mRNA and protein synthesis in
astrocytes. However, no T0901317 protection was found in apoE
KO astrocyte cultures. Next we added the human apoE3 which be-
haves functionally like mouse apoE [24] to apoE KO astrocyte cul-
ture and observed that apoE protected astrocytes from hypoxia-
induced apoptosis in a concentration dependent manner (Fig. 3).
Fig. 6. ApoE protected astrocyte from glutamate induced apoptosis. No effect of
T0901317 (300 nM added 48 h prior to glutamate exposure and maintained in the
culture media throughout the experiment) was observed in glutamate-treated
(50 mM for 24 h) apoE KO astrocytes. NC: normal control. ⁄P < 0.05 for glutamate-
treated apoE WT astrocytes compared with apoE KO astrocytes; #P < 0.05 for
glutamate + T0901317 treated apoE WT astrocytes compared with glutamate-
treated apoE WT astrocytes.
Fig. 5. Comparative effects of apoE and MK-801 on hypoxia-induced astrocyte
apoptosis. ApoE KO astrocyte cultures were pretreated with ApoE3 (1 mM), MK-
801(10 lM), or both ApoE3 and MK-801 for 30 min, then exposed to hypoxia for
6 h. Both ApoE3 and MK-801 conferred protection, but the effects were not additive.
⁄P < 0.05 as compared to normoxia; #P < 0.05 as compared to hypoxia alone.
Fig. 4. ApoE decreased the ischemia-induced level of glutamate. The level of
extracellular glutamate was measured by the Hitachi L-8800 automatic amino acid
analyzer. A signiﬁcant decrease (⁄P < 0.05) in extracellular glutamate level was
found in hypoxia-treated apoE WT astrocytes compared with apoE KO astrocytes;
#P < 0.05 for hypoxia + T0901317(300 nM added 48 h prior to hypoxia and main-
tained in the culture media throughout the experiment) treated apoEWT astrocytes
compared with hypoxia-treated apoE WT astrocytes.
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action in pathologicalmechanisms involving both neuronal damage
and protection [25]. The protective effects of apoE on hypoxia-in-
duced apoptosis of astrocytes strongly suggest that astrocyte may
play an important role in ischemic damage of neurons.
Our study showed that ApoE reduced glutamate concentration
after hypoxia in astrocytes (Fig. 4). Glutamate is the principal excit-
atory neurotransmitter in the central nervous system, but it is also
a potent neurotoxin that lead to cell death in the case of hypoxia
[26,27]. Lee et al. have shown that apoE increased the rate of glu-
tamate uptake via the high afﬁnity transporter in neuronal-glia cell
cultures exposed to hydrogen peroxide [28]. The astrocytic gluta-
mate transporters GLT-1 and GLAST, regulate extracellular gluta-
mate level and maintain glutamate homeostasis [29]. However,
whether the lowered levels of extracellular glutamate were due
to apoE’s modulation of glutamate transporters needs further
investigation.
Studies have also reported that glutamate contributes to neuro-
nal hypoxic injury by activating NMDA receptors [30]. Likeneurons, glial cells also are vulnerable to glutamate insults under
hypoxia conditions [21]. Moreover, hypoxia causes astrocytic mito-
chondrial dysfunction, thus leading to a loss of cellular and mito-
chondrial ion gradients with cellular calcium inﬂux that can
trigger glutamate release directly, contributing to neuronal excito-
toxicity [31]. Our data show that MK-801, a non-competitive
NMDA receptor antagonist, provided a protective effect against hy-
poxia-induced apoptosis in astrocytes after hypoxia. Moreover, the
effect of apoE3 and MK-801 were not additive (Fig. 5). Thus, we
speculate that apoE protects astrocytes from hypoxia-induced
apoptosis through NMDA receptor.
In this report, we found that apoE exerted a protective effect
against glutamate toxicity in astrocyte cultures (Fig. 6), which
was consistent with earlier observations of Lee et al. [28]. These
investigators also found a protective effect of apoE on glutamate-
induced LDH release in vitro using mixed neuronal-glial cell cul-
tures. However, Kitagawa et al. found that no signiﬁcant difference
in neuronal-glial cell viability was observed after exposure to glu-
tamate between apoE KO and wild-type mice [32]. These discrep-
ancies may be due to differences in methodology and experimental
design. For example, Kitagawa et al. treated cells with 50 or
100 lM glutamate for 15 min rather than the 50 mM for 24 h in
our study. It is worth noting that few cells underwent apoptosis
in cultures treated with glutamate <50 mM for 24 h [16].
Cellular apoE and plasma apoE exist as multiple glycosylated
and sialylated glycoforms, which vary in charge because of variable
sialylation [33]. Moreover, the more complicated structures on
plasma and cellular/secreted apoE remain unidentiﬁed and thus
may lead to different effects of the apoE on neuronal response to
injury. Overall, our study showed that apoE protected astrocytes
from hypoxia induced apoptosis, the mechanism for the protection
was related to reducing the level of extracellular glutamate,
decreasing the activation of NMDA receptors and related excitoxic-
ity in astrocytes exposed to hypoxia. Thus, we speculate that apoE
protects astrocytes from hypoxia induced apoptosis by modulating
secondary glutamate excitotoxic damage. These ﬁndings suggest
that enhancement of apoE secretion in astrocytes might provide
a novel strategy in the protection of neuronal ischemic injury.
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